Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Standard Dose
200MG;EQ 25MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE is listed in Drugs@FDA under application 214053 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE Form and strength TABLET;ORAL - 200MG;EQ 25MG BASE Sponsor APOTEX Submission history Latest submission status date: 2024-05-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE is listed in Drugs@FDA under application 214053 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE Form and strength TABLET;ORAL - 200MG;EQ 25MG BASE Sponsor APOTEX Submission history Latest submission status date: 2024-05-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.